Biological Intellectual Property Protection Act of 2025

# Biological Intellectual Property Protection Act of 2025 - Summary **What the Bill Would Do** This bill aims to protect intellectual property rights related to biological materials and research. While specific provisions aren't detailed in the available information, bills of this type typically establish legal protections for companies and researchers who develop new biological products, genetic materials, or biotechnology innovations. The goal is generally to give developers exclusive rights to their biological creations for a set period, similar to how patents work for other inventions. **Who It Affects** The bill would primarily impact biotechnology companies, pharmaceutical firms, academic research institutions, and individual researchers working with biological materials and genetic engineering.

It could also affect farmers, healthcare providers, and consumers depending on how broadly the protections are written—for example, if it covers genetically modified crops or new medical treatments. **Current Status** As of now, the bill (S 3452) is in committee and has not yet been brought up for a full Senate vote. It was introduced by Senator Tom Cotton (R-AR) in the 119th Congress. The bill would need to pass committee review, then secure approval from both the Senate and House before being sent to the President for signature to become law.